Using Conjoint Analysis to Elicit Benefit-Risk Preferences for Different Treatment Options Among Psoriasis Patients Receiving Systemic Treatment
Preprint
- 10 July 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: Psoriasis has a huge impact on patient’s life. Treatment dissatisfaction and non-adherence are common among patients with psoriasis, partly due to discord-ance between individual preferences and recommended treatments. The modern strategy for psoriasis should be focused on human centric treatment that recognizes the needs and preferences of patients with a goal for safe, effective, quality, and ac-ceptable health services for a lifetime. The aim of this analysis was to capture patients’ preferences with moderate-to-severe psoriasis regarding various treatment attributes. Methods: Development of a specialized questionnaire containing four attributes with three levels each was used, followed by an orthogonal plan based on conjoint analysis. Nine combinations of therapeutic scenarios were produced as a result, to investigate participants’ preferences. Respondents were asked to rank alternatives from best to worst. Results: The risk of developing pneumonia or other serious infection within a decade, seems to affect more the overall preference of patients with an implied assigned value of 37. The second attribute was the type and frequency of the administration with a value of 27 followed by the treatment effectiveness with great improvement of body surface with a value of 25. The lowest utility (11) was sustainability of long-term re-mission of psoriasis. Conclusions: Psoriasis patients want safe, effective, and easy to administer treatments.Keywords
All Related Versions
- Version 1, 2025-07-10, Preprints
- Published version: Therapeutics, 2 (4), 19.
This publication has 17 references indexed in Scilit:
- Patient preference study for different characteristics of systemic psoriasis treatments (Protimisis)Dermatologic Therapy, 2018
- PsoriasisThe Lancet, 2015
- Eliciting Preferences to Inform Patient-Centred Policies: the Case of PsoriasisPharmacoEconomics, 2014
- The impact of psoriasis on work‐related problems: a multicenter cross‐sectional surveyJournal of the European Academy of Dermatology and Venereology, 2013
- Patient Preferences for Psoriasis TreatmentsArchives of Dermatology, 2011
- Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task ForceValue in Health, 2011
- Definition of treatment goals for moderate to severe psoriasis: a European consensusArchives of Dermatological Research, 2010
- European patient perspectives on the impact of psoriasis: the EUROPSO patient membership surveyBritish Journal of Dermatology, 2006
- Psoriasis causes as much disability as other major medical diseasesJournal of the American Academy of Dermatology, 1999
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994